Pharmacy spend, particularly around GLP-1 medications, is reshaping employer health plan economics. This session explores how insurers and benefits professionals are responding to rapidly rising drug utilization and pricing pressures. How are underwriting and pricing adapting? What utilization controls are being implemented? And how are stop-loss carriers adjusting thresholds and structures? The discussion focuses on the intersection of medical trend, pharmacy management, and employer benefit design — offering a clear view of one of the most significant cost drivers in health insurance today.